Filing Flows › Vycor Medical (VYCO) › R&D spending
Vycor Medical (VYCO) R&D spending by quarter
Vycor Medical's R&D spending was $4K in Q2 2025 (second quarter 2025), -27% from Q1 2025. Over the last 3 quarters it ranged from $4K (Q2 2025) to $7K (Q4 2024).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2025 | $4K | -27% | — |
| Q1 2025 | $6K | -13% | — |
| Q4 2024 | $7K | — | — |
Q2 2025 at a glance
Vycor Medical, Q2 2025: revenue $496K (+22% year over year), operating margin 10.3%, net earnings $24K, operating cash flow $47K. The chart follows the revenue to costs, profit and cash.
Questions
What is Vycor Medical's R&D spending?
Vycor Medical's R&D spending was $4K in Q2 2025 (second quarter 2025), -27% from Q1 2025.
How has Vycor Medical's R&D spending changed?
Over the last 3 quarters it ranged from $4K (Q2 2025) to $7K (Q4 2024).